NXTC
$10.32+1.01 (+10.78%)
Market OpenUpdated 2:58 PM EDT
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.
$10.32+1.01 (+10.78%)
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.